In a recent international consensus published in Nature Medicine, T2DM is defined as “a disease characterized by the gradual decline of β cell insulin secretion function, often accompanied by excessive obesity and insulin resistance” [2]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.